Mepolizumab: 240563, Anti-IL-5 Monoclonal Antibody - GlaxoSmithKline, Anti-Interleukin-5 Monoclonal Antibody - GlaxoSmithKline, SB 240563

Author： Adis International Limited

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.9, Iss.2, 2008-01, pp. : 125-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody

By Smith Deborah A.

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 215-227

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline extends preferential pricing

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline stops salmeterol study

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline Medal of Merit 2008

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 4, 2008-12 ,pp. : 305-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

GlaxoSmithKline Medal of Merit 2010

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 4, 2010-12 ,pp. : 318-321

John Wiley & Sons Inc

Access to resources Recommend Favorite